The demand for CBD is unstoppable, and the FDA knows it…
Our community of like-minded investors here at the National Institute for Cannabis Investors has known this from the beginning – CBD is here to stay.
You know Executive Director Don Yocham‘s personal story about how CBD helps improve his recovery time after a tough workout. Many of you have also shared the benefits you’ve experienced from CBD and cannabis-based medicine.
Well, the Food and Drug Administration (FDA) finally got the memo.
FDA Commissioner Dr. Stephen Hahn recently said that “We have to be open to the fact that there might be some value in these products, and certainly Americans think that’s the case.”
CBD Is Here to Stay
The momentum for CBD is too big to stop. In fact, in just three short years, experts believe CBD sales will be up 3,622%.
Regulations are still a little murky, but just think about how far we have come.
Just a few years ago, most people had never even heard about CBD or knew anything about the powerful compounds found in the cannabis plant.
Is CBD giant, Charlotte’s Web, worth holding on to? Find out.
Today, CBD is everywhere, from Walgreens to Sheetz.
And in the video below, Don is going to let you know exactly what Dr. Hahn’s comments mean for investors.
Then, be sure to watch Don’s video interview with the CEO of a tiny but mighty CBD company out of Oregon right here.
4 responses to “FDA’s Latest Comments Signal Strong Support for CBD”
March 16 2020